Inflammation is a beneficial and physiological process, but there are a number of
inflammatory diseases which have detrimental effects on the body. In addition, the drugs …

Advanced therapy medicinal products (ATMPs) offer new prospects to improve the treatment
of conditions with unmet medical needs. Kidney diseases are a current major health concern …

The increase in T helper 17 cell (Th17)-mediated pro-inflammatory response and decrease
in regulatory T cell (Treg)-mediated anti-inflammatory effect aggravate renal tubular …

Mesenchymal stem cell (MSC) transplantation has emerged as a promising strategy for the
treatment of acute kidney injury (AKI). However, MSC-based therapies are limited by their …

Acute kidney injury is a frequent complication of hospitalized patients and significantly
increases morbidity and mortality, worsening costs and length of hospital stay. Despite this …

Objective. Acute kidney injury (AKI) usually occurs during sepsis. Inflammation factors, such
as high‐mobility group box 1 (HMGB1), are dramatically upregulated under septic …

The occurrence of acute kidney injury (AKI) is elevated, one of the main causes is ischemia-
reperfusion (I/R). However, no specific therapy is currently available to treat I/R-induced AKI …

Drug-induced nephrotoxicity is an important and increasing cause of acute kidney injury
(AKI), which accounts for approximately 20% of hospitalized patients. Previous reviews …

Cancer-related anemia (CRA) negatively influences cancer patients' survival, disease
progression, treatment efficacy, and quality of life (QOL). Current treatments such as iron …